Cargando…
Exploration of the underlying biological differences and targets in ovarian cancer patients with diverse immunotherapy response
BACKGROUND: Preclinical trials of immunotherapy in ovarian cancer (OC) have shown promising results. This makes it meaningful to prospectively examine the biological mechanisms explaining the differences in response performances to immunotherapy among OC patients. METHODS: Open-accessed data was obt...
Autores principales: | Chen, Jinjin, Chen, Surong, Dai, Xichao, Ma, Liang, Chen, Yu, Bian, Weigang, Sun, Yunhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521167/ https://www.ncbi.nlm.nih.gov/pubmed/36189254 http://dx.doi.org/10.3389/fimmu.2022.1007326 |
Ejemplares similares
-
Efficacy and safety of irinotecan combined with raltitrexed or irinotecan monotherapy for salvage chemotherapy of esophageal squamous cell cancer: A prospective, open label, randomized phase II study
por: Dai, Xichao, et al.
Publicado: (2023) -
Research into the biological differences and targets in lung cancer patients with diverse immunotherapy responses
por: Zhang, Xunlang, et al.
Publicado: (2022) -
Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies
por: Muccioli, Maria, et al.
Publicado: (2014) -
Efficacy evaluation of multi-immunotherapy in ovarian cancer: From bench to bed
por: Hu, Xiaoyi, et al.
Publicado: (2022) -
Improving Cancer Immunotherapy: Exploring and Targeting Metabolism in Hypoxia Microenvironment
por: Wei, Jinfen, et al.
Publicado: (2022)